{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:05:27Z","timestamp":1783915527367,"version":"3.55.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05242-8","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:15:47Z","timestamp":1774581347000},"page":"13479-13496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulation of mTOR, NLRP3, and Nrf2\/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis"],"prefix":"10.1007","volume":"399","author":[{"given":"Hayam Ali","family":"AlRasheed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M.","family":"Mosalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Bahaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed M.","family":"Salahuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir O.","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alrubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amsha S.","family":"Alsegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"El-Khateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Kh.","family":"Elmahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Elshorbagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd El Razeq A.","family":"Meselhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Wahsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"10","key":"5242_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105213","volume":"22","author":"NM Abd El-Fadeal","year":"2021","unstructured":"Abd El-Fadeal NM, Nafie MS, K. El-kherbetawy M, El-Mistekawy A, Mohammad HM, Elbahaie AM et al (2021) Antitumor activity of nitazoxanide against colon cancers: molecular docking and experimental studies based on wnt\/\u03b2-catenin signaling inhibition. Int J Mol Sci 22(10):5213","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5242_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3109\/08923973.2011.559475","volume":"33","author":"E Aktunc","year":"2011","unstructured":"Aktunc E, Kayhan B, Arasli M, Gun BD, Barut F (2011) The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. Immunopharmacol Immunotoxicol 33(4):667\u2013675","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"5242_CR3","doi-asserted-by":"publisher","first-page":"1381523","DOI":"10.3389\/fphar.2024.1381523","volume":"15","author":"KM Aldossary","year":"2024","unstructured":"Aldossary KM, Ali LS, Abdallah MS, Bahaa MM, Elmasry TA, Elberri EI et al (2024) Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK\/NLRP3 inflammasome and IL-6\/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study. Front Pharmacol 15:1381523","journal-title":"Front Pharmacol"},{"key":"5242_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lfs.2018.05.048","volume":"207","author":"FE Ali","year":"2018","unstructured":"Ali FE, Bakr AG, Abo-Youssef AM, Azouz AA, Hemeida RA (2018) Targeting Keap-1\/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis. Life Sci 207:50\u201360","journal-title":"Life Sci"},{"key":"5242_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119433","volume":"276","author":"FE Ali","year":"2021","unstructured":"Ali FE, Elfiky MM, Fadda WA, Ali HS, Mahmoud AR, Mohammedsaleh ZM et al (2021) Regulation of IL-6\/STAT-3\/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: novel mechanistic insight. Life Sci 276:119433","journal-title":"Life Sci"},{"issue":"11","key":"5242_CR6","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1007\/s11033-022-07822-2","volume":"49","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE-S (2022) Nitazoxanide and COVID-19: a review. Mol Biol Rep 49(11):11169\u201311176","journal-title":"Mol Biol Rep"},{"issue":"9","key":"5242_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093077","volume":"14","author":"HA AlRasheed","year":"2025","unstructured":"AlRasheed HA, El-Haggar SM, Hegazy SK, Maher MM, Bahgat MM, Bahaa MM (2025) Repurposing atorvastatin, HMGCO-A reductase inhibitor, in patients with ulcerative colitis: a randomized controlled study. J Clin Med 14(9):3077","journal-title":"J Clin Med"},{"issue":"6","key":"5242_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/mi.2014.35","volume":"7","author":"R Caruso","year":"2014","unstructured":"Caruso R, Marafini I, Franz\u00e8 E, Stolfi C, Zorzi F, Monteleone I et al (2014) Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut. Mucosal Immunol 7(6):1467\u20131479","journal-title":"Mucosal Immunol"},{"issue":"3","key":"5242_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/jcm9030800","volume":"9","author":"GP Caviglia","year":"2020","unstructured":"Caviglia GP, Rosso C, Stalla F, Rizzo M, Massano A, Abate ML et al (2020) On-treatment decrease of serum interleukin-6 as a predictor of clinical response to biologic therapy in patients with inflammatory bowel diseases. J Clin Med 9(3):800","journal-title":"J Clin Med"},{"issue":"2","key":"5242_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbrc.2010.04.117","volume":"396","author":"D Chartoumpekis","year":"2010","unstructured":"Chartoumpekis D, Ziros PG, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG, Habeos IG (2010) Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K\/Akt pathway. Biochem Biophys Res Commun 396(2):463\u2013466","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5242_CR11","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower\u2013Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140(6):1785\u201394. e4","journal-title":"Gastroenterology"},{"issue":"6","key":"5242_CR12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/ibd.21822","volume":"18","author":"SD Crockett","year":"2012","unstructured":"Crockett SD, Hansen RA, St\u00fcrmer T, Schectman R, Darter J, Sandler RS et al (2012) Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis 18(6):1048\u20131056","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"5242_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015081","volume":"5","author":"C-M Cruciat","year":"2013","unstructured":"Cruciat C-M, Niehrs C (2013) Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb Perspect Biol 5(3):a015081","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"5242_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/01.mca.0000131573.31966.34","volume":"15","author":"J Davignon","year":"2004","unstructured":"Davignon J, Jacob RF, Mason RP (2004) The antioxidant effects of statins. Coron Artery Dis 15(5):251\u2013258","journal-title":"Coron Artery Dis"},{"issue":"2","key":"5242_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12664-013-0420-4","volume":"33","author":"P Dhamija","year":"2014","unstructured":"Dhamija P, Hota D, Kochhar R, Sachdev A, Chakrabarti A (2014) Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis. Indian J Gastroenterol 33(2):151\u2013156","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"5242_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/08923973.2015.1021357","volume":"37","author":"EM El Morsy","year":"2015","unstructured":"El Morsy EM, Kamel R, Ahmed MA (2015) Attenuating effects of coenzyme Q10 and amlodipine in ulcerative colitis model in rats. Immunopharmacol Immunotoxicol 37(3):244\u2013251","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"5242_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/08923973.2021.1878214","volume":"43","author":"NA El-Mahdy","year":"2021","unstructured":"El-Mahdy NA, El-Sayad ME-S, El-Kadem AH, Abu-Risha SE-S (2021) Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1\/sphingosine 1 phosphate signaling pathway. Immunopharmacol Immunotoxicol 43(2):192\u2013202","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"5242_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/fcp.12563","volume":"35","author":"NA El\u2010Mahdy","year":"2021","unstructured":"El\u2010Mahdy NA, El\u2010Sayad MES, El\u2010Kadem AH, Abu\u2010Risha SES (2021) Targeting IL\u201010, ZO\u20101 gene expression and IL\u20106\/STAT\u20103 trans\u2010signaling by a combination of atorvastatin and mesalazine to enhance anti\u2010inflammatory effects and attenuates progression of oxazolone\u2010induced colitis. Fundam Clin Pharmacol 35(1):143\u2013155","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"5242_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10787-021-00818-7","volume":"29","author":"MA El-Rous","year":"2021","unstructured":"El-Rous MA, Saber S, Raafat EM, Ahmed AA (2021) Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NF\u03baB\/AMPK\/NLRP3 axis. Inflammopharmacology 29(4):1169\u20131185","journal-title":"Inflammopharmacology"},{"issue":"4","key":"5242_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000129209","volume":"24","author":"R Fabia","year":"1992","unstructured":"Fabia R, Willen R, Ar\u2019Rajab A, Andersson R, Ahren B, Bengmark S (1992) Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 24(4):211\u2013225","journal-title":"Eur Surg Res"},{"key":"5242_CR21","doi-asserted-by":"crossref","unstructured":"Fan L, Qiu X-x, Zhu Z-y, Lv J-l, Lu J, Mao F, et al. Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice. Acta Pharmacologica Sinica. 2019;40(10):1279\u201391.","DOI":"10.1038\/s41401-019-0220-1"},{"key":"5242_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.12659\/MSM.912032","volume":"25","author":"T Fang","year":"2019","unstructured":"Fang T, Guo B, Xue L, Wang L (2019) Atorvastatin prevents myocardial fibrosis in spontaneous hypertension via interleukin-6 (IL-6)\/signal transducer and activator of transcription 3 (STAT3)\/endothelin-1 (ET-1) pathway. Med Sci Monit 25:318","journal-title":"Med Sci Monit"},{"key":"5242_CR23","doi-asserted-by":"crossref","unstructured":"Fragoso MA, Patel AK, Nakamura RE, Yi H, Surapaneni K, Hackam AS. The Wnt\/\u03b2-catenin pathway cross-talks with STAT3 signaling to regulate survival of retinal pigment epithelium cells. 2012.","DOI":"10.1371\/journal.pone.0046892"},{"key":"5242_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exger.2014.01.015","volume":"52","author":"X Gong","year":"2014","unstructured":"Gong X, Ma Y, Ruan Y, Fu G, Wu S (2014) Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS\/iNOS imbalance in rat aorta. Exp Gerontol 52:9\u201317","journal-title":"Exp Gerontol"},{"issue":"7","key":"5242_CR25","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/bjp.2008.369","volume":"155","author":"O Grip","year":"2008","unstructured":"Grip O, Janciauskiene S, Bredberg A (2008) Use of atorvastatin as an anti-inflammatory treatment in Crohn\u2019s disease. Br J Pharmacol 155(7):1085\u20131092","journal-title":"Br J Pharmacol"},{"key":"5242_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00109-008-0393-4","volume":"86","author":"IG Habeos","year":"2008","unstructured":"Habeos IG, Ziros PG, Chartoumpekis D, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG (2008) Simvastatin activates Keap1\/Nrf2 signaling in rat liver. J Mol Med 86:1279\u20131285","journal-title":"J Mol Med"},{"issue":"2","key":"5242_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/jcb.26320","volume":"119","author":"F Han","year":"2018","unstructured":"Han F, Xiao QQ, Peng S, Che XY, Jiang LS, Shao Q et al (2018) Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT\/mTOR signaling pathway. J Cell Biochem 119(2):1604\u20131615","journal-title":"J Cell Biochem"},{"issue":"1","key":"5242_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ydbio.2005.11.011","volume":"290","author":"J Hao","year":"2006","unstructured":"Hao J, Li T-G, Qi X, Zhao D-F, Zhao G-Q (2006) WNT\/\u03b2-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev Biol 290(1):81\u201391","journal-title":"Dev Biol"},{"issue":"7","key":"5242_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1517\/14656566.7.7.953","volume":"7","author":"A Hemphill","year":"2006","unstructured":"Hemphill A, Mueller J, Esposito M (2006) Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 7(7):953\u2013964","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"5242_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrm3293","volume":"13","author":"RH Houtkooper","year":"2012","unstructured":"Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13(4):225\u2013238","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5242_CR31","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.3389\/av.2023.11612","volume":"67","author":"Z Huang","year":"2023","unstructured":"Huang Z, Zheng H, Wang Y, Wang X, Wang C, Liu Y et al (2023) The modulation of metabolomics and antioxidant stress is involved in the effect of nitazoxanide against influenza a virus in vitro. Acta Virol 67:11612","journal-title":"Acta Virol"},{"key":"5242_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2013.03.015","volume":"61","author":"J-w Hwang","year":"2013","unstructured":"Hwang J-w, Yao H, Caito S, Sundar IK, Rahman I (2013) Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic Biol Med 61:95\u2013110","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"5242_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.36348\/sjm.2023.v08i01.004","volume":"8","author":"MS Islam","year":"2023","unstructured":"Islam MS, Ahmed SS, Mahmud S, Al Mamun A, Hasan MK, Hasan N et al (2023) Nitazoxanide in acute rotavirus diarrhea-a randomized controlled trial study in a tertiary care hospital in Bangladesh. Saudi J Med 8(1):24\u201332","journal-title":"Saudi J Med"},{"issue":"5","key":"5242_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/life12050760","volume":"12","author":"D Khayatan","year":"2022","unstructured":"Khayatan D, Razavi SM, Arab ZN, Khanahmadi M, Momtaz S, Butler AE et al (2022) Regulatory effects of statins on SIRT1 and other sirtuins in cardiovascular diseases. Life 12(5):760","journal-title":"Life"},{"key":"5242_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10787-016-0305-0","volume":"25","author":"AE Khodir","year":"2017","unstructured":"Khodir AE, Atef H, Said E, ElKashef HA, Salem HA (2017) Implication of Nrf2\/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis. Inflammopharmacology 25:119\u2013135","journal-title":"Inflammopharmacology"},{"issue":"24","key":"5242_CR36","doi-asserted-by":"publisher","first-page":"11580","DOI":"10.1158\/0008-5472.CAN-06-3562","volume":"66","author":"TO Khor","year":"2006","unstructured":"Khor TO, Huang M-T, Kwon KH, Chan JY, Reddy BS, Kong A-N (2006) Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium\u2013induced colitis. Cancer Res 66(24):11580\u201311584","journal-title":"Cancer Res"},{"key":"5242_CR37","doi-asserted-by":"crossref","unstructured":"Kim J-H, Park G-Y, Bang SY, Park SY, Bae S-K, Kim Y. Crocin suppresses LPS-stimulated expression of inducible nitric oxide synthase by upregulation of heme oxygenase-1 via calcium\/calmodulin-dependent protein kinase 4. Mediators of inflammation. 2014;2014.","DOI":"10.1155\/2014\/728709"},{"issue":"1-2","key":"5242_CR38","first-page":"12","volume":"690","author":"J Kim","year":"2010","unstructured":"Kim J, Cha Y-N, Surh Y-J (2010) A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res-Fund Mol Mech Mutagen 690(1\u20132):12\u201323","journal-title":"Mutat Res-Fund Mol Mech Mutagen"},{"key":"5242_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.biopha.2016.04.043","volume":"82","author":"F Kong","year":"2016","unstructured":"Kong F, Ye B, Lin L, Cai X, Huang W, Huang Z (2016) Atorvastatin suppresses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-\u03baB signaling in PMA-stimulated THP-1 monocytes. Biomed Pharmacother 82:167\u2013172","journal-title":"Biomed Pharmacother"},{"issue":"23","key":"5242_CR40","doi-asserted-by":"publisher","first-page":"10415","DOI":"10.7150\/thno.49603","volume":"10","author":"Y Kong","year":"2020","unstructured":"Kong Y, Feng W, Zhao X, Zhang P, Li S, Li Z et al (2020) Statins ameliorate cholesterol-induced inflammation and improve AQP2 expression by inhibiting NLRP3 activation in the kidney. Theranostics 10(23):10415","journal-title":"Theranostics"},{"issue":"4","key":"5242_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/imm.12662","volume":"149","author":"A Lei","year":"2016","unstructured":"Lei A, Yang Q, Li X, Chen H, Shi M, Xiao Q et al (2016) Atorvastatin promotes the expansion of myeloid-derived suppressor cells and attenuates murine colitis. Immunology 149(4):432\u2013446","journal-title":"Immunology"},{"issue":"12","key":"5242_CR42","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.4049\/jimmunol.1100099","volume":"186","author":"W Li","year":"2011","unstructured":"Li W, Henderson LJ, Major EO, Al-Harthi L (2011) IFN-\u03b3 mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the \u03b2-catenin pathway (DKK1) in a STAT 3-dependent manner. J Immunol 186(12):6771\u20136778","journal-title":"J Immunol"},{"issue":"10","key":"5242_CR43","first-page":"4160","volume":"8","author":"Q Li","year":"2016","unstructured":"Li Q, Dong Q-T, Yang Y-J, Tian X-Q, Jin C, Huang P-S et al (2016) AMPK-mediated cardioprotection of atorvastatin relates to the reduction of apoptosis and activation of autophagy in infarcted rat hearts. American Journal of Translational Research 8(10):4160","journal-title":"American Journal of Translational Research"},{"issue":"10","key":"5242_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03114-4","volume":"11","author":"Q Li","year":"2020","unstructured":"Li Q, Liu Y, Wang X, He F, Tang L (2020) Activation of mTORC1 by LSECtin in macrophages directs intestinal repair in inflammatory bowel disease. Cell Death Dis 11(10):1\u201314","journal-title":"Cell Death Dis"},{"issue":"3","key":"5242_CR45","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.apsb.2021.09.009","volume":"12","author":"F Li","year":"2022","unstructured":"Li F, Jiang M, Ma M, Chen X, Zhang Y, Zhang Y et al (2022) Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice. Acta Pharmaceutica Sinica b 12(3):1322\u20131338","journal-title":"Acta Pharmaceutica Sinica b"},{"issue":"2","key":"5242_CR46","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3892\/etm.2017.4576","volume":"14","author":"MW Liu","year":"2017","unstructured":"Liu MW, Liu R, Wu HY, Chen M, Dong MN, Huang YQ et al (2017) Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression. Exp Ther Med 14(2):917\u2013930","journal-title":"Exp Ther Med"},{"key":"5242_CR47","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11064-019-02738-z","volume":"44","author":"H Liu","year":"2019","unstructured":"Liu H, Yang J, Wang K, Niu T, Huang D (2019) Moderate-and low-dose of atorvastatin alleviate cognition impairment induced by high-fat diet via Sirt1 activation. Neurochem Res 44:1065\u20131078","journal-title":"Neurochem Res"},{"issue":"4","key":"5242_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"5242_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111013","volume":"395","author":"J Luo","year":"2024","unstructured":"Luo J, Peng Y, Cheng X-F, Wu S-Z, Zhao Y-D, Chang L et al (2024) Nitazoxanide protects against experimental ulcerative colitis through improving intestinal barrier and inhibiting inflammation. Chem Biol Interact 395:111013","journal-title":"Chem Biol Interact"},{"issue":"1","key":"5242_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/bph.15949","volume":"180","author":"MH Ma","year":"2023","unstructured":"Ma MH, Li FF, Li WF, Zhao H, Jiang M, Yu YY et al (2023) Repurposing nitazoxanide as a novel anti-atherosclerotic drug based on mitochondrial uncoupling mechanisms. Br J Pharmacol 180(1):62\u201379","journal-title":"Br J Pharmacol"},{"issue":"7","key":"5242_CR51","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.3390\/ijms26073148","volume":"26","author":"B Ma","year":"2025","unstructured":"Ma B, Barathan M, Ng MH, Law JX (2025) Oxidative stress, gut microbiota, and extracellular vesicles: interconnected pathways and therapeutic potentials. Int J Mol Sci 26(7):3148","journal-title":"Int J Mol Sci"},{"key":"5242_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43141-020-00055-5","volume":"18","author":"DB Mahmoud","year":"2020","unstructured":"Mahmoud DB, Shitu Z, Mostafa A (2020) Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19? J Genet Eng Biotechnol 18:1\u201310","journal-title":"J Genet Eng Biotechnol"},{"issue":"7","key":"5242_CR53","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/jmf.2012.2672","volume":"16","author":"H Malekinejad","year":"2013","unstructured":"Malekinejad H, Shafie-Irannejad V, Hobbenaghi R, Tabatabaie SH, Moshtaghion S-M (2013) Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in rats. J Med Food 16(7):593\u2013601","journal-title":"J Med Food"},{"issue":"2","key":"5242_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020288","volume":"18","author":"F Mar\u00edn-Aguilar","year":"2017","unstructured":"Mar\u00edn-Aguilar F, Pavillard LE, Giampieri F, Bull\u00f3n P, Cordero MD (2017) Adenosine monophosphate (AMP)-activated protein kinase: a new target for nutraceutical compounds. Int J Mol Sci 18(2):288","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5242_CR55","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13(9):1016\u20131023","journal-title":"Nat Cell Biol"},{"issue":"3","key":"5242_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/gut.39.3.407","volume":"39","author":"A Millar","year":"1996","unstructured":"Millar A, Rampton D, Chander C, Claxson A, Blades S, Coumbe A et al (1996) Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39(3):407","journal-title":"Gut"},{"key":"5242_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.diff.2019.01.002","volume":"108","author":"L Moparthi","year":"2019","unstructured":"Moparthi L, Koch S (2019) Wnt signaling in intestinal inflammation. Differentiation 108:24\u201332","journal-title":"Differentiation"},{"issue":"4","key":"5242_CR58","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/jac\/dkl553","volume":"59","author":"DM Musher","year":"2007","unstructured":"Musher DM, Logan N, Mehendiratta V, Melgarejo NA, Garud S, Hamill RJ (2007) Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother 59(4):705\u2013710","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5242_CR59","first-page":"997","volume":"17","author":"Y Naito","year":"2006","unstructured":"Naito Y, Katada K, Takagi T, Tsuboi H, Isozaki Y, Handa O et al (2006) Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. Int J Mol Med 17(6):997\u20131004","journal-title":"Int J Mol Med"},{"issue":"3","key":"5242_CR60","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.immuni.2010.03.001","volume":"32","author":"P Nava","year":"2010","unstructured":"Nava P, Koch S, Laukoetter MG, Lee WY, Kolegraff K, Capaldo CT et al (2010) Interferon-\u03b3 regulates intestinal epithelial homeostasis through converging \u03b2-catenin signaling pathways. Immunity 32(3):392\u2013402","journal-title":"Immunity"},{"issue":"6","key":"5242_CR61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169(6):985\u2013999","journal-title":"Cell"},{"issue":"11","key":"5242_CR62","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1161\/ATVBAHA.110.210500","volume":"30","author":"H Ota","year":"2010","unstructured":"Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S et al (2010) Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol 30(11):2205\u20132211","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5242_CR63","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","volume":"73","author":"N Parsamanesh","year":"2019","unstructured":"Parsamanesh N, Moossavi M, Bahrami A, Fereidouni M, Barreto G, Sahebkar A (2019) NLRP3 inflammasome as a treatment target in atherosclerosis: a focus on statin therapy. Int Immunopharmacol 73:146\u2013155","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"5242_CR64","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4196\/kjpp.2014.18.4.279","volume":"18","author":"PK Randhawa","year":"2014","unstructured":"Randhawa PK, Singh K, Singh N, Jaggi AS (2014) A review on chemical-induced inflammatory bowel disease models in rodents. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 18(4):279","journal-title":"The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology"},{"key":"5242_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10787-016-0263-6","volume":"24","author":"A Rashidian","year":"2016","unstructured":"Rashidian A, Muhammadnejad A, Dehpour A-R, Mehr SE, Akhavan MM, Shirkoohi R et al (2016) Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4\/NF-kB signaling pathway. Inflammopharmacology 24:109\u2013118","journal-title":"Inflammopharmacology"},{"issue":"7","key":"5242_CR66","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1172\/JCI67227","volume":"123","author":"NB Ruderman","year":"2013","unstructured":"Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123(7):2764\u20132772","journal-title":"J Clin Invest"},{"issue":"1","key":"5242_CR67","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10787-020-00730-6","volume":"29","author":"S Saber","year":"2021","unstructured":"Saber S, El-Kader EMA (2021) Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90\/NLRP3 interaction and inducing autophagy in rats. Inflammopharmacology 29(1):237\u2013251","journal-title":"Inflammopharmacology"},{"issue":"3","key":"5242_CR68","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/MIB.0000000000000597","volume":"22","author":"BE Sands","year":"2016","unstructured":"Sands BE, Joshi S, Haddad J, Freudenberg JM, Oommen DE, Hoffmann E et al (2016) Assessing colonic exposure, safety, and clinical activity of SRT2104, a novel oral SIRT1 activator, in patients with mild to moderate ulcerative colitis. Inflamm Bowel Dis 22(3):607\u2013614","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"5242_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1124\/jpet.102.044099","volume":"305","author":"M Sasaki","year":"2003","unstructured":"Sasaki M, Bharwani S, Jordan P, Joh T, Manas K, Warren A et al (2003) The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis. J Pharmacol Exp Ther 305(1):78\u201385","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"5242_CR70","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) Mtor signaling in growth, metabolism, and disease. Cell 168(6):960\u2013976","journal-title":"Cell"},{"issue":"1","key":"5242_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cyto.2013.12.010","volume":"66","author":"M Sharma","year":"2014","unstructured":"Sharma M, Mohapatra J, Wagh A, Patel HM, Pandey D, Kadam S et al (2014) Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation. Cytokine 66(1):30\u201339","journal-title":"Cytokine"},{"key":"5242_CR72","doi-asserted-by":"crossref","unstructured":"Shou J, Kong X, Wang X, Tang Y, Wang C, Wang M, et al. Tizoxanide inhibits inflammation in LPS-activated RAW264. 7 macrophages via the suppression of NF-\u03baB and MAPK activation. Inflammation. 2019;42:1336\u201349.","DOI":"10.1007\/s10753-019-00994-3"},{"key":"5242_CR73","doi-asserted-by":"crossref","unstructured":"Shou J, Wang M, Cheng X, Wang X, Zhang L, Liu Y, et al. Tizoxanide induces autophagy by inhibiting PI3K\/Akt\/mTOR pathway in RAW264. 7 macrophage cells. Archives of Pharmacal Research. 2020;43:257\u201370.","DOI":"10.1007\/s12272-019-01202-4"},{"issue":"3","key":"5242_CR74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.amjcard.2008.03.057","volume":"102","author":"U Singh","year":"2008","unstructured":"Singh U, Devaraj S, Jialal I, Siegel D (2008) Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. Am J Cardiol 102(3):321\u2013325","journal-title":"Am J Cardiol"},{"issue":"3","key":"5242_CR75","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1124\/jpet.109.160838","volume":"332","author":"UP Singh","year":"2010","unstructured":"Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M et al (2010) Resveratrol (trans-3, 5, 4\u2032-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-\u03baB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther 332(3):829\u2013839","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"5242_CR76","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1021\/acsinfecdis.0c00478","volume":"7","author":"AV Stachulski","year":"2020","unstructured":"Stachulski AV, Taujanskas J, Pate SL, Rajoli RK, Aljayyoussi G, Pennington SH et al (2020) Therapeutic potential of nitazoxanide: an appropriate choice for repurposing versus SARS-CoV-2? ACS Infectious Diseases 7(6):1317\u20131331","journal-title":"ACS Infectious Diseases"},{"issue":"25","key":"5242_CR77","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.jacc.2013.08.1627","volume":"62","author":"S Subramanian","year":"2013","unstructured":"Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM et al (2013) High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. J Am Coll Cardiol 62(25):2382\u20132391","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5242_CR78","first-page":"14837","volume":"8","author":"G Sun","year":"2015","unstructured":"Sun G, Li Y, Ji Z (2015) Atorvastatin attenuates inflammation and oxidative stress induced by ischemia\/reperfusion in rat heart via the Nrf2 transcription factor. Int J Clin Exp Med 8(9):14837","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"5242_CR79","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2265028","volume":"15","author":"Y Tie","year":"2023","unstructured":"Tie Y, Huang Y, Chen R, Li L, Chen M, Zhang S (2023) Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets. Gut Microbes 15(2):2265028","journal-title":"Gut Microbes"},{"issue":"3","key":"5242_CR80","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/mol.116.108100","volume":"92","author":"S Wang","year":"2017","unstructured":"Wang S, Xie X, Lei T, Zhang K, Lai B, Zhang Z et al (2017) Statins attenuate activation of the NLRP3 inflammasome by oxidized LDL or TNF\u03b1 in vascular endothelial cells through a PXR-dependent mechanism. Mol Pharmacol 92(3):256\u2013264","journal-title":"Mol Pharmacol"},{"issue":"19","key":"5242_CR81","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1158\/0008-5472.CAN-10-1626","volume":"70","author":"P-M Yang","year":"2010","unstructured":"Yang P-M, Liu Y-L, Lin Y-C, Shun C-T, Wu M-S, Chen C-C (2010) Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res 70(19):7699\u20137709","journal-title":"Cancer Res"},{"issue":"7","key":"5242_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23074","volume":"36","author":"M Yildirim","year":"2022","unstructured":"Yildirim M, Kayalar O, Atahan E, Oztay F (2022) Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis. J Biochem Mol Toxicol 36(7):e23074","journal-title":"J Biochem Mol Toxicol"},{"key":"5242_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.719984","volume":"12","author":"ME Youssef","year":"2021","unstructured":"Youssef ME, Abd El-Fattah EE, Abdelhamid AM, Eissa H, El-Ahwany E, Amin NA et al (2021) Interference with the AMPK\u03b1\/mTOR\/NLRP3 signaling and the IL-23\/IL-17 axis effectively protects against the dextran sulfate sodium intoxication in rats: a new paradigm in empagliflozin and metformin reprofiling for the management of ulcerative colitis. Front Pharmacol 12:719984","journal-title":"Front Pharmacol"},{"issue":"02","key":"5242_CR84","first-page":"102","volume":"29","author":"Z Zeng","year":"2013","unstructured":"Zeng Z, Zhan L, Liao H, Chen L, Lv X (2013) Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4\/NF-\u03baB signaling pathway. Planta Med 29(02):102\u2013109","journal-title":"Planta Med"},{"issue":"1","key":"5242_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov 6(1):1\u201322","journal-title":"Cell Discov"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05242-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05242-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05242-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:43:17Z","timestamp":1783914197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05242-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5242"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05242-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}